Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isatis Root Eye Drops is a Traditional Chinese Medicine (TCM) ophthalmic formulation derived from the root of *Isatis indigotica* Fort. (Radix Isatidis). It is primarily indicated for the treatment of acute bacterial conjunctivitis and other inflammatory ocular conditions. The extract contains a variety of bioactive compounds, including alkaloids such as indirubin and isatin, organic acids, and sulfur-containing compounds, which collectively provide broad-spectrum antibacterial, antiviral, and anti-inflammatory activities. In clinical settings, it is evaluated both as a monotherapy and as an adjunctive treatment alongside conventional antibiotics like levofloxacin to improve clinical outcomes and accelerate the resolution of symptoms like conjunctival congestion and discharge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isatis root eye drops.